Multicenter integration analysis of TRP channels revealed potential mechanisms of immunosuppressive microenvironment activation and identified a machine learning‐derived signature for improving outcomes in gliomas
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14816 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Yuntao Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Glioma, Machine Learning, Tumor Microenvironment, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Aim
This study aimed to explore the mechanisms of transient receptor potential (TRP) channels on the immune microenvironment and develop a TRP‐related signature for predicting prognosis, immunotherapy response, and drug sensitivity in gliomas.
Methods
Based on the unsupervised clustering algorithm, we identified novel TRP channel clusters and investigated their biological function, immune microenvironment, and genomic heterogeneity. In vitro and in vivo experiments revealed the association between TRPV2 and macrophages. Subsequently, based on 96 machine learning algorithms and six independent glioma cohorts, we constructed a machine learning‐based TRP channel signature (MLTS). The performance of the MLTS in predicting prognosis, immunotherapy response, and drug sensitivity was evaluated.
Results
Patients with high expression levels of TRP channel genes had worse prognoses, higher tumor mutation burden, and more activated immunosuppressive microenvironment. Meanwhile, TRPV2 was identified as the most essential regulator in TRP channels. TRPV2 activation could promote macrophages migration toward malignant cells and alleviate glioma prognosis. Furthermore, MLTS could work independently of common clinical features and present stable and superior prediction performance.
Conclusion
This study investigated the comprehensive effect of TRP channel genes in gliomas and provided a promising tool for designing effective, precise treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
- Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Gastroenterology, 72nd Group Army Hospital, Huzhou University, Huzhou, Zhejiang, China.
ORCID-Profile: Xiaoxing Xiong, Qianxue Chen
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Li, Y., Zhang, Y., Feng, S., Zhu, H., Xing, Y., Xiong, X., & Chen, Q. (2024). Multicenter integration analysis of TRP channels revealed potential mechanisms of immunosuppressive microenvironment activation and identified a machine learning‐derived signature for improving outcomes in gliomas. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14816
Vancouver
Li Y, Zhang Y, Feng S, Zhu H, Xing Y, Xiong X, et al. Multicenter integration analysis of TRP channels revealed potential mechanisms of immunosuppressive microenvironment activation and identified a machine learning‐derived signature for improving outcomes in gliomas. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14816
BibTeX
@article{Li2024,
author = {Li, Yuntao and Zhang, Yonggang and Feng, Shi and Zhu, Hua and Xing, Ying and Xiong, Xiaoxing and Chen, Qianxue},
title = {Multicenter integration analysis of TRP channels revealed potential mechanisms of immunosuppressive microenvironment activation and identified a machine learning‐derived signature for improving outcomes in gliomas},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14816}
}
EUVIMED